Papers
7
Total Citations
71
H-Index
5
About
Sofia Gereta is a rising leader in urologic oncology, whose work focuses on optimizing surgical outcomes and healthcare value through robotic-assisted surgery. Her most influential research challenges traditional inpatient paradigms, demonstrating that same-day discharge after robotic-assisted radical prostatectomy is safe and cost-effective—a shift accelerated by the COVID-19 pandemic. Her 2023 study on this topic, with 28 citations, used time-driven activity-based costing to show comparable complication rates and higher patient satisfaction versus inpatient care. Gereta has extended this value-based methodology to robotic partial and radical nephrectomy, and she has advanced the field of testicular cancer surgery by refining robotic-assisted retroperitoneal lymph node dissection (R-RPLND), reducing morbidity compared to open approaches. She also investigates practical challenges in the operating room, such as impaired visualization during robotic surgery, highlighting archaic issues that persist in modern systems. With additional work on partial gland cryoablation and age-related outcomes in prostatectomy, Gereta’s research bridges surgical innovation, cost-effectiveness, and patient-centered care, establishing her as a key voice in the future of minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7